Outsourced microbiological support to hospital-based surveillance of CDI aims to increase the capacity of laboratories in EU/EEA Member States to perform diagnostic practices with high diagnostic accuracy and acquire comparable typing data from C. difficile isolates.
The fifth meeting of the Hepatitis B and C Network aims to bring together experts from across the EU to discuss how Europe can improve its response to the epidemics of hepatitis B and C with a focus on surveillance, estimating prevalence, and the monitoring of response.
For EAAD 2018 ECDC will host the event “One Health to Keep Antibiotics Working” where ECDC will present the latest estimates of the health burden of antibiotic resistance, and the new data on the prevalence of healthcare-associated infections and of antimicrobial consumption in acute care hospitals and long-term care facilities in the EU/EEA.
The 31st IUSTI (International Union Against Sexually Transmitted Infections) Europe Congress addressed the broad range of science and clinical practice in the field of sexually transmitted infections.
Infographics on acute care hospitals, healthcare-associated infections, antimicrobial use, antimicrobial resistance, based on the ECDC Point prevalence survey
The ninth Healthcare Infection Society (HIS) International Conference was a three-day conference focussing on infection prevention and control, organised by the HIS in collaboration with the French Society of Hospital Hygiene (SF2H). The conference programme covered a range of key topics such as epidemiology, surveillance, information technology in infection prevention and control, decontamination, blood borne viruses, antimicrobial resistance and rapid diagnostic methods.
The 2015 meeting of the Joint ECDC/WHO Surveillance Network for Tuberculosis was held in The Hague, the Netherlands, on 26-27 May 2015. The meeting was organised jointly by the European Centre for Disease Prevention and Control (ECDC) and WHO/Europe for TB surveillance experts from WHO European region including European Union/European Economic Area (EU/EEA) Member States (MSs). The participants included 47 nominated contact points for TB surveillance from 42 countries, as well as experts from ECDC and WHO/Europe, WHO headquarters and country offices. In addition, experts from seven EU Enlargement Countries and from the KNCV TB Foundation (the Netherlands) attended the meeting as observers.
The aims of the meeting were to enable sharing of experiences and good practices between member states, review ECDC’s current programme of work and to help determine future priorities for surveillance, prevention and control of the hepatitis B virus (HBV) and hepatitis C virus (HCV) across Europe.